Resources

Lessons from COVID-19: Advancing Development of Universal Influenza Vaccines
What can COVID-19 response teach us about the future of universal influenza vaccine R&D? Read our latest white paper for findings from our 2020 literature review, interviews and survey with insights from over 200 professionals from 45 countries.

Universal Influenza Vaccine Candidate Advances
Promising results in a recent study from Krammer et al. report their chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

Now is the Time to Protect the World from Influenza
Astonishing progress toward successful COVID-19 vaccines has built momentum to conquer infectious disease threats. In our latest video, infectious disease experts Harvey Fineberg, Julie Gerberding, Edward Holmes, Michael Osterholm and Lynda Stuart say a full-court press for a universal influenza vaccine should be next.

In the Age of Emerging Pandemics, Influenza is the Devil We Know
Pandemic expert Harvey Fineberg hopes COVID-19 is the wake-up call the world needs to prevent the next pandemic. How can we learn from COVID-19 in a future some have described as an “age of pandemics,” during which outbreaks will become increasingly frequent? We zero in on the pathogen we know best: influenza.





